DrugDashboards

Lidocaine Hydrochloride and Dextrose

Lidocaine Hydrochloride · LIDOCAINE HYDROCHLORIDE 4 mg/mL · Injection, Solution · Intravenous · Baxter Healthcare Corporation

NDC 00338-0409-03 · 18 BAG in 1 CARTON / 500 mL in 1 BAG · NDA · View full market →

The short version

18 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “demand increase for the drug”. One of its named manufacturing plants, Baxter Healthcare Corporation, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$0.0030per billing unit (1 MG)HCPCS J2002 · Jul 1, 2026
  • Federal contracts pay (FSS)$68.04per package of 18X500MLBaxter Healthcare Corporation · Sep 17, 2025

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$6.80
Reported to Texas DSHS · 2026 annual filing · Baxter Healthcare Corporation

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 1 MG
$0.003
HCPCS J2002 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$469
774 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.6%chance of a new FDA shortage posting for lidocaine hydrochloride (injectable) in the next 90 days

sterile injectable · 4 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months)

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA018461
TE code
AP
Approval date
Jan 1, 1982
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10)Jun 13, 2018
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10)Jun 13, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20)Jun 13, 2018
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10)Jun 13, 2018
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10)Jun 13, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20)Jun 13, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50)Jun 13, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25)Jun 13, 2018
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25)Jun 13, 2018
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74)Feb 20, 2018
    Demand increase for the drug
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02)Feb 20, 2018
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05)Feb 20, 2018
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30)Feb 20, 2018
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05)Feb 20, 2018
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02)Feb 20, 2018
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03)Oct 25, 2017
    month 107 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02)Oct 25, 2017
    month 107 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17)Oct 14, 2016
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37)Oct 14, 2016
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05)Feb 22, 2012
    month 175 — 9× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Lidocaine Hydrochloride (Injection, Solution)

LabelerStrengthFirst seenLast seen
Anthea Pharma Private LimitedLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Asclemed USA, Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Asclemed USA, Inc.LIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Camber Pharmaceuticals, Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 5 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mLJul 15, 2026Sep 3, 2026
Henry Schein, Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mLJul 15, 2026Sep 3, 2026
Henry Schein, Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Hikma Pharmaceuticals USA Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.LIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.LIDOCAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Lifestar Pharma LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Lifestar Pharma LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
NorthStar RxLLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mLJul 15, 2026Sep 3, 2026
NorthStar RxLLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
ProPharma DistributionLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Sandoz Inc.LIDOCAINE HYDROCHLORIDE 10 mg/mLSep 3, 2026Sep 3, 2026
Sandoz Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLSep 3, 2026Sep 3, 2026
Sportpharm LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
A-S Medication SolutionsLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Anthea Pharma Private LimitedLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationLIDOCAINE HYDROCHLORIDE 8 mg/mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationLIDOCAINE HYDROCHLORIDE 4 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.LIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 15 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mLAug 26, 2026Sep 2, 2026
Henry Schein, Inc.LIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Lidocaine Hydrochloride and Dextrose — NDC 00338-0409-03," retrieved September 3, 2026, https://drugdashboards.com/drug/00338040903.

Free to cite with attribution — see how the data is put together.